Podcast 22: Interview with Aaron Kesselheim about his meta-analysis of the efficacy of proprietary versus generic cardiovascular drugs.

This week, in addition to the usual news roundup, we talk with Dr. Aaron Kesselheim about his JAMA paper on the equivalence between proprietary and generic cardiovascular drugs. The data and the editorials are often at odds on this question.

Have a listen, and if you want to react to any of this, call 1-617-440-4374.

Links for this issue:

–Vitamin D

American Academy of Dermatology guidelines

Physician’s First Watch coverage

–Controlling hypertension

NEJM abstract

Journal Watch Cardiology coverage

Physician’s First Watch coverage

— Work hours for residents

Institute of Medicine recommendations

Physician’s First Watch coverage

–Depression in stable coronary disease

Pubmed abstract

Journal Watch Cardiology coverage

–Generic versus proprietary cardiovascular drugs

JAMA abstract

Physician’s First Watch coverage

The post Podcast 22: Interview with Aaron Kesselheim about his meta-analysis of the efficacy of proprietary versus generic cardiovascular drugs. first appeared on Clinical Conversations.